Tempest Therapeutics Overview
Tempest Therapeutics Discounted Cash Flow
DCF Analysis for TPST.
Get informed when a big investor buys or sells
+ FollowFair Value
$-0.10
Current Fair Value
$-0.10
↓ 108.4% Downside
Overvalued by 108.4% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison